Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apoptosis-related proteins in synovial tissue encompass a group of molecules that regulate programmed cell death (apoptosis) within the synovium, the tissue lining joints. These proteins are critical for maintaining tissue homeostasis and are dysregulated in diseases like rheumatoid arthritis (RA), contributing to pathological synovial hyperplasia and joint destruction. Key players include the Fas/FasL system, Bcl-2 family proteins, caspases, TRAIL/DR5, XIAP, Sentrin/SUMO, and Synoviolin. In RA, an imbalance favoring survival over death occurs in fibroblast-like synoviocytes (FLSs), leading to persistent inflammation and joint damage. Targeting these molecules represents a potential therapeutic strategy for restoring normal turnover and homeostasis.
Modulation of apoptotic pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptosis-related Proteins in Synovial Tissue.